Align Technology, Inc. (ALGN) EV/FCF Ratio: 17.17x
Is Align Technology, Inc.’s EV/FCF ratio high or low?
Align Technology, Inc.'s EV/FCF ratio of 17.17x is 56% below its 5-year average of 39.00x, near the low end of its 5-year range (12.22x–98.94x).
The EV/FCF ratio for Align Technology, Inc. (ALGN) is 17.17x as of Tuesday, June 9, 2026. It is below its 12-month average by 3.19% (17.74x).
ALGN EV/FCF Ratio Chart
ALGN Average EV/FCF Ratio Chart
ALGN Current vs Average EV/FCF Ratio Chart
ALGN EV/FCF Ratio Metrics
EV/FCF RATIO
17.17x
EV/FCF RATIO AVG TTM
17.74x
EV/FCF RATIO AVG 3Y
29.63x
EV/FCF RATIO AVG 5Y
39.00x
EV/FCF RATIO AVG 10Y
52.87x
EV/FCF RATIO AVG 15Y
43.38x
EV/FCF RATIO AVG 20Y
70.10x
CURRENT VS TTM AVG
-3.19%
CURRENT VS 3Y AVG
-42.05%
CURRENT VS 5Y AVG
-55.97%
CURRENT VS 10Y AVG
-67.52%
CURRENT VS 15Y AVG
-60.42%
CURRENT VS 20Y AVG
-75.51%
ALGN Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Align Technology, Inc. (ALGN) | — | 17.17x | 17.74x | 29.63x | 39.00x |
| Charles River Laboratories International, Inc. (CRL) | $9.14B | 31.07x | 21.19x | 29.11x | 35.24x |
| Hologic, Inc. (HOLX) | $16.97B | 17.53x | 16.89x | 18.61x | 15.13x |
| Bio-Rad Laboratories, Inc. (BIO) | $8.03B | 24.87x | 25.01x | 43.94x | 51.13x |
| Moderna, Inc. (MRNA) | $18.94B | 27.77x | 20.23x | 39.97x | 29.53x |
| Hims & Hers Health, Inc. (HIMS) | $6.46B | 99.26x | 82.84x | 71.51x | 71.51x |
| BioNTech SE (BNTX) | $21.87B | 9.68x | 18.15x | 9.84x | 13.27x |
| Mettler-Toledo International Inc. (MTD) | $23.50B | 32.45x | 33.77x | 33.52x | 38.39x |
| Waters Corporation (WAT) | $24.19B | 134.83x | 42.98x | 42.91x | 41.35x |
| Veeva Systems Inc. (VEEV) | $27.37B | 50.23x | 29.28x | 32.90x | 38.29x |
Cash Flow Valuation Comparison
EV/FCF
17.2x
P/FCF
18.6x
FCF Yield
5.38%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Align Technology, Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Align Technology, Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The EV/FCF ratio for ALGN stock is 17.17x.
- Is Align Technology, Inc.'s EV/FCF ratio high or low?
- Align Technology, Inc.'s EV/FCF ratio of 17.17x is 56% below its 5-year average of 39.00x, near the low end of its 5-year range (12.22x–98.94x).
- What is the TTM average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The TTM average EV/FCF ratio for ALGN stock is 17.74x.
- What is the 3Y average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The 3Y average EV/FCF ratio for ALGN stock is 29.63x.
- What is the 5Y average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The 5Y average EV/FCF ratio for ALGN stock is 39.00x.
- What is the 10Y average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The 10Y average EV/FCF ratio for ALGN stock is 52.87x.
- What is the 15Y average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The 15Y average EV/FCF ratio for ALGN stock is 43.38x.
- What is the 20Y average EV/FCF ratio for Align Technology, Inc. (ALGN)?
- The 20Y average EV/FCF ratio for ALGN stock is 70.10x.
Align Technology, Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-09 | 17.17x |
| 2026-06-08 | 16.54x |
| 2026-06-05 | 16.09x |
| 2026-06-04 | 16.14x |
| 2026-06-03 | 15.46x |
| 2026-06-02 | 15.98x |
| 2026-06-01 | 16.30x |
| 2026-05-29 | 16.84x |
| 2026-05-28 | 16.66x |
| 2026-05-27 | 15.58x |
| 2026-05-26 | 15.65x |
| 2026-05-22 | 15.65x |
| 2026-05-21 | 15.59x |
| 2026-05-20 | 15.63x |
| 2026-05-19 | 14.77x |
| 2026-05-18 | 15.15x |
| 2026-05-15 | 14.99x |
| 2026-05-14 | 15.33x |
| 2026-05-13 | 15.46x |
| 2026-05-12 | 15.88x |
| 2026-05-11 | 15.76x |
| 2026-05-08 | 16.19x |
| 2026-05-07 | 16.15x |
| 2026-05-06 | 16.73x |
| 2026-05-05 | 18.78x |
| 2026-05-04 | 19.16x |
| 2026-05-01 | 20.02x |
| 2026-04-30 | 19.66x |
| 2026-04-29 | 19.95x |
| 2026-04-28 | 19.82x |
| 2026-04-27 | 20.72x |
| 2026-04-24 | 21.31x |
| 2026-04-23 | 21.44x |
| 2026-04-22 | 22.09x |
| 2026-04-21 | 21.99x |
| 2026-04-20 | 21.56x |
| 2026-04-17 | 21.37x |
| 2026-04-16 | 20.75x |
| 2026-04-15 | 20.94x |
| 2026-04-14 | 20.71x |
| 2026-04-13 | 20.23x |
| 2026-04-10 | 19.32x |
| 2026-04-09 | 19.49x |
| 2026-04-08 | 19.76x |
| 2026-04-07 | 18.56x |
| 2026-04-06 | 19.16x |
| 2026-04-02 | 19.01x |
| 2026-04-01 | 19.27x |
| 2026-03-31 | 19.11x |
| 2026-03-30 | 18.49x |
| 2026-03-27 | 18.50x |
| 2026-03-26 | 19.82x |
| 2026-03-25 | 20.18x |
| 2026-03-24 | 20.07x |
| 2026-03-23 | 20.25x |
| 2026-03-20 | 19.32x |
| 2026-03-19 | 19.69x |
| 2026-03-18 | 19.23x |
| 2026-03-17 | 19.68x |
| 2026-03-16 | 18.87x |
| 2026-03-13 | 18.24x |
| 2026-03-12 | 18.56x |
| 2026-03-11 | 19.52x |
| 2026-03-10 | 18.87x |
| 2026-03-09 | 19.55x |
| 2026-03-06 | 19.42x |
| 2026-03-05 | 19.61x |
| 2026-03-04 | 20.41x |
| 2026-03-03 | 20.47x |
| 2026-03-02 | 21.24x |
| 2026-02-27 | 21.37x |
| 2026-02-26 | 22.62x |
| 2026-02-25 | 22.47x |
| 2026-02-24 | 22.15x |
| 2026-02-23 | 21.61x |
| 2026-02-20 | 22.73x |
| 2026-02-19 | 22.65x |
| 2026-02-18 | 22.83x |
| 2026-02-17 | 22.37x |
| 2026-02-13 | 22.31x |
| 2026-02-12 | 21.94x |
| 2026-02-11 | 23.68x |
| 2026-02-10 | 23.53x |
| 2026-02-09 | 23.04x |
| 2026-02-06 | 22.42x |
| 2026-02-05 | 20.89x |
| 2026-02-04 | 19.06x |
| 2026-02-03 | 18.51x |
| 2026-02-02 | 19.35x |
| 2026-01-30 | 19.28x |
| 2026-01-29 | 19.42x |
| 2026-01-28 | 19.52x |
| 2026-01-27 | 19.79x |
| 2026-01-26 | 19.87x |
| 2026-01-23 | 20.01x |
| 2026-01-22 | 20.03x |
| 2026-01-21 | 20.16x |
| 2026-01-20 | 19.60x |
| 2026-01-16 | 20.36x |
| 2026-01-15 | 20.36x |
| 2026-01-14 | 20.07x |
| 2026-01-13 | 20.19x |
| 2026-01-12 | 20.42x |
| 2026-01-09 | 20.52x |
| 2026-01-08 | 20.24x |
| 2026-01-07 | 19.76x |
| 2026-01-06 | 19.87x |
| 2026-01-05 | 18.91x |
| 2026-01-02 | 18.38x |
| 2025-12-31 | 18.40x |
| 2025-12-30 | 18.65x |
| 2025-12-29 | 18.61x |
| 2025-12-26 | 18.68x |
| 2025-12-24 | 18.61x |
| 2025-12-23 | 18.48x |
| 2025-12-22 | 18.80x |
| 2025-12-19 | 18.59x |
| 2025-12-18 | 19.07x |
| 2025-12-17 | 18.96x |
| 2025-12-16 | 19.26x |
| 2025-12-15 | 19.24x |
| 2025-12-12 | 19.58x |
| 2025-12-11 | 19.38x |
| 2025-12-10 | 19.48x |
| 2025-12-09 | 18.76x |
| 2025-12-08 | 18.59x |
| 2025-12-05 | 18.53x |
| 2025-12-04 | 18.49x |
| 2025-12-03 | 18.25x |
| 2025-12-02 | 17.73x |
| 2025-12-01 | 17.19x |
| 2025-11-28 | 17.25x |
| 2025-11-26 | 17.26x |
| 2025-11-25 | 17.29x |
| 2025-11-24 | 16.80x |
| 2025-11-21 | 16.66x |
| 2025-11-20 | 15.41x |
| 2025-11-19 | 15.53x |
| 2025-11-18 | 15.35x |
| 2025-11-17 | 15.39x |
| 2025-11-14 | 15.97x |
| 2025-11-13 | 16.26x |
| 2025-11-12 | 16.55x |
| 2025-11-11 | 16.91x |
| 2025-11-10 | 16.11x |
| 2025-11-07 | 15.67x |
| 2025-11-06 | 15.53x |
| 2025-11-05 | 15.98x |
| 2025-11-04 | 13.37x |
| 2025-11-03 | 13.68x |
| 2025-10-31 | 13.61x |
| 2025-10-30 | 13.67x |
| 2025-10-29 | 12.97x |
| 2025-10-28 | 13.10x |
| 2025-10-27 | 13.37x |
| 2025-10-24 | 13.32x |
| 2025-10-23 | 13.41x |
| 2025-10-22 | 13.36x |
| 2025-10-21 | 13.43x |
| 2025-10-20 | 13.29x |
| 2025-10-17 | 12.81x |
| 2025-10-16 | 12.75x |
| 2025-10-15 | 12.60x |
| 2025-10-14 | 12.74x |
| 2025-10-13 | 12.72x |
| 2025-10-10 | 12.32x |
| 2025-10-09 | 12.97x |
| 2025-10-08 | 13.10x |
| 2025-10-07 | 12.82x |
| 2025-10-06 | 12.93x |
| 2025-10-03 | 13.00x |
| 2025-10-02 | 12.63x |
| 2025-10-01 | 12.50x |
| 2025-09-30 | 12.25x |
| 2025-09-29 | 12.38x |
| 2025-09-26 | 12.36x |
| 2025-09-25 | 12.22x |
| 2025-09-24 | 12.57x |
| 2025-09-23 | 12.66x |
| 2025-09-22 | 12.89x |
| 2025-09-19 | 12.91x |
| 2025-09-18 | 13.04x |
| 2025-09-17 | 12.71x |
| 2025-09-16 | 12.96x |
| 2025-09-15 | 12.88x |
| 2025-09-12 | 12.93x |
| 2025-09-11 | 13.40x |
| 2025-09-10 | 13.08x |
| 2025-09-09 | 13.40x |
| 2025-09-08 | 13.50x |
| 2025-09-05 | 13.74x |
| 2025-09-04 | 13.27x |
| 2025-09-03 | 13.02x |
| 2025-09-02 | 13.53x |
| 2025-08-29 | 14.05x |
| 2025-08-28 | 13.96x |
| 2025-08-27 | 14.05x |
| 2025-08-26 | 14.03x |
| 2025-08-25 | 14.37x |
| 2025-08-22 | 14.86x |
| 2025-08-21 | 13.91x |
| 2025-08-20 | 14.22x |
| 2025-08-19 | 14.24x |
| 2025-08-18 | 14.36x |
| 2025-08-15 | 14.10x |
| 2025-08-14 | 14.14x |
| 2025-08-13 | 14.45x |
| 2025-08-12 | 13.89x |
| 2025-08-11 | 13.28x |
| 2025-08-08 | 13.82x |
| 2025-08-07 | 13.70x |
| 2025-08-06 | 13.50x |
| 2025-08-05 | 15.10x |
| 2025-08-04 | 14.88x |
| 2025-08-01 | 14.74x |
| 2025-07-31 | 13.86x |
| 2025-07-30 | 22.56x |
| 2025-07-29 | 22.82x |
| 2025-07-28 | 22.99x |
| 2025-07-25 | 22.80x |
| 2025-07-24 | 22.40x |
| 2025-07-23 | 22.63x |
| 2025-07-22 | 21.45x |
| 2025-07-21 | 20.86x |
| 2025-07-18 | 21.07x |
| 2025-07-17 | 21.24x |
| 2025-07-16 | 21.01x |
| 2025-07-15 | 21.31x |
| 2025-07-14 | 22.07x |
| 2025-07-11 | 22.41x |
| 2025-07-10 | 22.67x |
| 2025-07-09 | 22.20x |
| 2025-07-08 | 21.62x |
| 2025-07-07 | 21.43x |
| 2025-07-03 | 21.77x |
| 2025-07-02 | 21.79x |
| 2025-07-01 | 21.48x |
| 2025-06-30 | 20.90x |
| 2025-06-27 | 20.81x |
| 2025-06-26 | 20.72x |
| 2025-06-25 | 20.65x |
| 2025-06-24 | 20.58x |
| 2025-06-23 | 20.21x |
| 2025-06-20 | 20.02x |
| 2025-06-18 | 19.81x |
| 2025-06-17 | 19.25x |
| 2025-06-16 | 20.11x |
| 2025-06-13 | 19.56x |
| 2025-06-12 | 20.01x |
| 2025-06-11 | 20.45x |
| 2025-06-10 | 20.75x |
| 2025-06-09 | 19.92x |
| 2025-06-06 | 19.88x |
| 2025-06-05 | 19.84x |
| 2025-06-04 | 19.81x |
| 2025-06-03 | 19.71x |
| 2025-06-02 | 19.64x |
| 2025-05-30 | 19.92x |
| 2025-05-29 | 20.17x |
| 2025-05-28 | 19.82x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Align Technology, Inc.
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Joseph Hogan